Interview with Megan Fookes, Director, Rare Voices
Rare Voices Australia is a new organisation that has been established after the national rare diseases symposium in…
Rare Voices
Last updated: 21.01.2019
Address: PO Box 4419 Castlecrag NSW 2068 Australia
Tel: +61 410 702 535
Web: http://rarevoices.org.au/
Company description
Rare Voices Australia (RVA) is a new organisation that has been established in response to the consensus call from over 200 national attendees at the inaugural ‘Awakening Australia to Rare Diseases’ international symposium held in Fremantle, Western Australia, in 2011.
Products and services
The primary objective of Rare Voices Australia is to unite and represent the interests of all Australians living with a rare disease or disorder, and their families, as one voice, with the immediate aim of increasing both public and political awareness of the burden of rare disease, and the ultimate aim of achieving better outcomes nationally for those whose lives are impacted.
As a strong and unified voice we can identify and address common issues; promote cohesive stakeholder collaborations and networks locally, nationally and internationally; lobby for improved access to information and best-practice standards of care for people living with rare conditions; influence public policy, and advocate for the development of a National Plan for Rare Diseases.
Interviews
Related
Global / PharmaBoardroom's Top 5 Op-Eds in 2021 (So Far)
As our thoughts here at PharmaBoardroom turn towards the summer holidays, we are happy to share the five most-read…
Australia / Opportunities for the Life Science Industry post-COVID
Regular PharmaBoardroom contributor Brendan Shaw outlines how his home country of Australia has so far successfully…
Australia / Growing Clinical Trials Even in Pandemic’s Wake
In an exclusive new podcast, DIA Global Forum Australia/New Zealand Regional Editor Richard Day (University of…
UK / New Post-Brexit Regulatory Alliance with Australia, Canada, Singapore & Switzerland
When the European Medicines Agency (EMA) relocated from London to Amsterdam after the UK announced its decision to…
Opinion / The Powerful Impact of Taking a Patient-Centric Approach in an Evolving Health Landscape
Janssen Australia & New Zealand’s Bruce Goodwin argues that greater adoption of patient-centric practices…
Interview with Mal Eutick, CEO, Phebra Australia
Can you start by giving our readers a brief overview of the company’s history here and your most notable…
Interview with Marisa Petersen, Managing Director, George Clinical, Australia
Would you begin by outlining the role & importance of George Clinical within the George Institute, highlighting…
Interview with Vlado Perkovich, Executive Director, The George Institute,…
Would you begin by giving an introduction to our international readers of the institute, highlighting recent…
Interview with Albert Spanos, General Manager, Celgene Australia
In our interviews we have been hearing two opinions on the success of PBS reforms: that it works as it should in…
Interview with George Varkanis, Vice President Asia Pacific, Celgene Australia
“Australia is not just a postbox for selling drugs; Celgene is committed to establishing a major presence in…
Interview with Azhar Mohammed, Managing Director, Dr Reddy’s Laboratories…
Dr. Reddy’s entered Australia under your leadership. Would you outline the key milestones & achievements?…
Interview with Azhar Mohammed, Managing Director, Dr Reddy's Laboratories…
Dr. Reddy’s entered Australia under your leadership. Would you outline the key milestones & achievements?…
